Aug 3

The Cannabis Conversation: Discussing the Risks with Adolescent Patients - Frankly Speaking Ep 496

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-496 Overview: Adolescents who use cannabis—especially at a younger age or higher frequency—face substantially elevated risks of mood ... Show More

13m 57s

Jul 27

Statins—Time to Stop the Worry! - Frankly Speaking Ep 495

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-495 Overview: Statin prescription labels and case reports list a variety of potential treatment-related adverse effects that often r ... Show More

11m 26s

Jul 20

Digital Dependence: Screening Adults for Screen Time - Frankly Speaking Ep 494

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-494 Overview: Primary care visits offer a valuable opportunity to identify and address excessive screen time—a health concern that c ... Show More

11m 34s

Dec 2018

ACE Inhibitors

This podcast reviews the pharmaceutical class ACE inhibitors. The therapeutic class is antihypertensives. Discussion of this medication and memory helps to remember this medication are included.

3m 28s

Apr 2018

DHP Calcium Channel Blockers RLP Episode – 012

On this episode, I discuss the pharmacology of calcium channel blockers. There is a few common side effects with these medications and they can lead to the prescribing cascade. I talk about an example in the podcast where they can cause edema which leads to a prescription for a d ... Show More

7m 17s

Feb 2018

Lisinopril Pharmacology – Episode 003

In the episode, I break down the pharmacology of lisinopril (and all ACE inhibitors). I also outline common adverse effects, drug interactions and its role in managing hypertension. Hope you enjoy the show and please feel free to reach out with feedback! All subscribers to the we ... Show More

10m 10s

Nov 2022

Nov 11, 2022 This Week in Cardiology Podcast

AHA 2022 Part 1: ISCHEMIA-EXTEND, STRONG-HF, chlorthalidone vs HCTZ, experts vs practitioners; torsemide vs furosemide; and TG lowering are discussed by John Mandrola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To ... Show More

22m 40s

Aug 2024

Cardiovascular System Pharmacology

In this episode, Dr Matt and Dr Mike discus drugs that are used to treat cardiovascular diseases.YouTube: https://www.youtube.com/@DrMattDrMike/Email: gubiosciences@gmail.comInstagram: @drmiketodorovicTwitter: @drmiketodorovicTikTok: @dr_mike_todorovicFor the A-Z episodes please ... Show More

1h 16m

May 2023

Amlodipine Pharmacology Podcast

On this episode of the Real Life Pharmacology Podcast, I discuss amlodipine pharmacology, adverse effects, and important drug interactions. I break down why edema occurs with amlodipine on this episode of the Real Life Pharmacology podcast. While beta-blockers are typically the f ... Show More

18m 33s

May 2021

#14: The Treatment of Hypertension: Medications to Use in These 8 Cases

On this episode, we’re presenting 8 different clinical scenarios of hypertension. For each case, what is the best anti-hypertensive therapy? What is the best treatment for a patient with hypertension and proteinuria? What is the best initial treatment for a patient with essential ... Show More

23m 32s

May 2024

May 10 2024 This Week in Cardiology

Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. To rea ... Show More

31m 56s

Feb 2024

Captopril Pharmacology Podcast – Episode 314

On this podcast episode, I discuss captopril pharmacology, kinetics, interactions, and much more! Captopril is an ACE Inhibitor. It can cause hyperkalemia, cough, and renal impairment. One of the notable issues with captopril is its relatively short half-life which requires it to ... Show More

14m 40s

May 2024

May 24 2024 This Week in Cardiology

Clues in SCAF, a DOAC antidote trial, another negative lytic trial in stroke, JAMA changes to observational studies, and BP in stroke care are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals ... Show More

28m 56s

ACE Inhibitors: Maybe Not for Hypertensi...